NEW YORK, July 20, 2023 /PRNewswire/ -- Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing immunogenic small molecule approaches in oncology, has expanded its clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback